Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Dữ liệu Lầu Năm Góc cho thấy hơn 200 binh sĩ Mỹ bị thương kể từ khi Mỹ nối lại giao tranh với Iran trong tháng 7

Dữ liệu Lầu Năm Góc cho thấy hơn 200 binh sĩ Mỹ bị thương kể từ khi Mỹ nối lại giao tranh với Iran trong tháng 7

Thế giới
(Baothanhhoa.vn) - Theo số liệu Bộ Quốc phòng Mỹ cập nhật ngày 26/7, hạng mục thống kê mới "Các chiến dịch ở nước ngoài" ghi nhận 4 quân nhân Mỹ thiệt mạng và 207 người bị thương kể từ ngày 7/7, thời điểm Washington xác định là bắt đầu vòng giao tranh mới với Iran.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh